Search | IOVS | ARVO Journals

View

Showing 1 – 9 of 9

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

LONG-TERM OUTCOMES OF SWITCHING TO AFLIBERCEPT FOR TREATMENT RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Kimberly Spooner; Thomas Hong; Rashmi Nair; Nicholas Chian Chiang Chow; Geoffrey Broadhead; Wijeyanthy Wijeyakumar; Andrew Chang

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):820. doi:

ARVO Annual Meeting Abstract September 2016

Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration Patients: 3-Year Outcomes

Wijeyanthy Wijeyakumar; Meidong Zhu; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4965. doi:

ARVO Annual Meeting Abstract September 2016

Quality of corneas from the donors with neovascular age-related macular degeneration

Meidong Zhu; Wijeyanthy Wijeyakumar; Bobak Bahrami; Jane Treloggen; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6211. doi:

ARVO Annual Meeting Abstract June 2015

Comparison of aflibercept treatment regimes for treatment-resistant neovascular age-related macular degeneration: 8 weekly versus an ‘as-needed’ regime

Wijeyanthy Wijeyakumar; Meidong Zhu; Geoffrey Broadhead; Thomas Hai Le Hong; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4620. doi:

ARVO Annual Meeting Abstract April 2014

Retinal Morphology Changes Following Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration

Geoffrey Broadhead; Thomas Hong; Haitao Li; Meidong Zhu; Wijeyanthy Wijeyakumar; Andrew Alexander Chang; Sydney Institute of Vision Science

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3924. doi:

ARVO Annual Meeting Abstract April 2014

Response of Pigment Epithelial Detachments following Intravitreal Aflibercept for Age-Related Macular Degeneration

Thomas Hong; Geoffrey Broadhead; Meidong Zhu; Haitao Li; Timothy Schlub; Wijeyanthy Wijeyakumar; Andrew Alexander Chang

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3937. doi:

ARVO Annual Meeting Abstract April 2014

Self-Controlled Comparison of the Anatomical and Visual Response to Intravitreal Ranibizumab and Aflibercept in Treatment-Resistant Age-Related Macular Degeneration

Andrew Alexander Chang; Thomas Hong; Geoffrey Broadhead; Nichole Diane Lucy Joachim; Adil Syed; Timothy Schlub; Wijeyanthy Wijeyakumar; Meidong Zhu

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3939. doi:

ARVO Annual Meeting Abstract April 2014

Changes in Quality of Life Among Patients Treated with Aflibercept for neovascular Age-related Macular Degeneration (nAMD)

Wijeyanthy Wijeyakumar; Thomas Hong; Geoffrey Broadhead; Haitao Li; Meidong Zhu; Andrew Alexander Chang; Sydney Institute of Vision Science

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3945. doi:

ARVO Annual Meeting Abstract June 2013

Macular Morphology Changes Following Intravitreal Aflibercept for Treatment-Resistant Exudative AMD

Geoffrey Broadhead; Haitao Li; Meidong Zhu; Jamie Chew; Wijeyanthy Wijeyakumar; Andrew Chang; Sydney Vitreoretinal Research Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3797. doi:

Advertisement